Related Experiment Videos
Histidine decarboxylase expression in human melanoma.
M Haak-Frendscho1, Z Darvas, H Hegyesi
1Immunology Department, Promega Corporation, Madison, Wisconsin, USA.
The Journal of Investigative Dermatology
|August 22, 2000
Summary
Histidine decarboxylase (HDC) is elevated in melanoma. This enzyme, crucial for histamine production, shows increased gene and protein expression in melanoma cells and tissues compared to normal melanocytes.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Histamine is involved in regulating cell proliferation in normal and cancerous tissues.
- Histidine decarboxylase (HDC) is the key enzyme in histamine synthesis.
- Understanding HDC's role in melanoma is crucial for therapeutic development.
Purpose of the Study:
- To investigate the gene and protein expression of histidine decarboxylase (HDC) in human melanoma.
- To compare HDC expression levels in melanoma cells and tissues versus normal melanocytes.
Main Methods:
- Gene expression analysis using reverse transcriptase polymerase chain reaction (RT-PCR) and in situ hybridization.
- Protein expression analysis via Western blot, flow cytometry, and immunohistochemistry.
- Development of a polyclonal chicken antibody against human HDC.
Main Results:
- HDC messenger RNA (mRNA) was detected in multiple human melanoma cell lines.
- Western blot confirmed HDC protein expression at approximately 54 kDa in melanoma cell lysates.
- Flow cytometry and immunohistochemistry revealed strong cytoplasmic HDC staining in melanoma cells and tissues, significantly higher than in normal melanocytes.
Conclusions:
- Gene and protein expression of histidine decarboxylase (HDC) is significantly elevated in human melanoma.
- HDC may play a critical role in melanoma development and progression.
- Targeting HDC could be a potential therapeutic strategy for melanoma.